# New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

> **NCT02318069** · PHASE2,PHASE3 · COMPLETED · sponsor: **Sormland County Council, Sweden** · enrollment: 250 (actual)

## Conditions studied

- Tick-borne Encephalitis

## Interventions

- **BIOLOGICAL:** FSME-immune

## Key facts

- **NCT ID:** NCT02318069
- **Lead sponsor:** Sormland County Council, Sweden
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2016-02
- **Final completion:** 2017-06
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2021-02-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02318069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02318069, "New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT02318069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*